Paradigm Medical Industries Inc. Stock Analysis PDMI
Paradigm Medical Industries, Inc. is a medical device manufacturing company, which engages in the design, development, and sale of technological diagnostic eye care instruments and related products for early detection of glaucoma, and other eye disorders. The company is headquartered in Salt Lake City, Utah. The firm markets its products to ophthalmologists, optometrists, universities, hospitals and clinics. The Company’s products include A-Scans, A/B Scans, Blood Flow Analyzer, Pachymeter, Field Perimeter, Corneal Topographers, Ocular Electrophysiology, UBMS, Endothelial camera and accessories. The P-2700 is a combination of A-Scan and B-Scan. Paradigm’s Blood Flow Analyzer (BFA) is a tonometer that offers measurement of Ocular Blood flow (OBF). The PARAVUE 300 Corneal Topographer is used in diagnostic and contact lens applications. Paramax provides the detection of glaucoma through its objective 90 second long PERG test. The P60 UBM is the Ultrasound Bio Microscope and provides unprecedented image accuracy. The PARACAM 1000 is a non-contact endothelial microscope.
Read More Paradigm Medical Industries Inc (PDMI) Chart
Key Statistics of Paradigm Medical Industries Inc (PDMI)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
150.00KP/E Ratio (TTM)
-52 Week Range
Market Cap
3249.00Avg. Volume
149.16KDividend Yield
-Financial Metrics & Statements of Paradigm Medical Industries Inc (PDMI)
FAQ's for Paradigm Medical Industries Inc (PDMI)
- According to Musaffa’s Shariah screening methodology, Paradigm Medical Industries Inc (PDMI) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.